These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12473572)

  • 21. A patient with progressive multiple myeloma treated successfully with arsenic trioxide after allogeneic bone marrow transplantation.
    Gesundheit B; Shapira MY; Ackerstein A; Resnik IB; Bitan M; Or R
    Acta Haematol; 2007; 117(2):119-21. PubMed ID: 17135719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A clinical and pharmacological study of arsenic trioxide in advanced multiple myeloma patients.
    Rousselot P; Larghero J; Arnulf B; Poupon J; Royer B; Tibi A; Madelaine-Chambrin I; Cimerman P; Chevret S; Hermine O; Dombret H; Claude Brouet J; Paul Fermand J
    Leukemia; 2004 Sep; 18(9):1518-21. PubMed ID: 15269785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of melphalan, arsenic trioxide and ascorbic acid combination therapy in patients with relapsed or refractory multiple myeloma: a prospective, multicentre, phase II, single-arm study.
    Berenson JR; Boccia R; Siegel D; Bozdech M; Bessudo A; Stadtmauer E; Talisman Pomeroy J; Steis R; Flam M; Lutzky J; Jilani S; Volk J; Wong SF; Moss R; Patel R; Ferretti D; Russell K; Louie R; Yeh HS; Swift RA
    Br J Haematol; 2006 Oct; 135(2):174-83. PubMed ID: 17010047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of arsenic trioxide on QT interval in patients with advanced malignancies.
    Barbey JT; Pezzullo JC; Soignet SL
    J Clin Oncol; 2003 Oct; 21(19):3609-15. PubMed ID: 14512391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Arsenic compounds in the treatment of multiple myeloma: a new role for a historical remedy.
    Berenson JR; Yeh HS
    Clin Lymphoma Myeloma; 2006 Nov; 7(3):192-8. PubMed ID: 17229334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arsenic trioxide: an emerging therapy for multiple myeloma.
    Munshi NC
    Oncologist; 2001; 6 Suppl 2():17-21. PubMed ID: 11331436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A phase II trial of arsenic trioxide for relapsed and refractory acute lymphoblastic leukemia.
    Litzow MR; Lee S; Bennett JM; Dewald GW; Gallagher RE; Jain V; Paietta EM; Racevskis J; Rousey SR; Mazza JJ; Tallman MS
    Haematologica; 2006 Aug; 91(8):1105-8. PubMed ID: 16870552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Green tea component, catechin, induces apoptosis of human malignant B cells via production of reactive oxygen species.
    Nakazato T; Ito K; Ikeda Y; Kizaki M
    Clin Cancer Res; 2005 Aug; 11(16):6040-9. PubMed ID: 16115949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Selected mechanisms of the therapeutic effect of arsenic trioxide in cancer treatment].
    Izdebska M; Grzanka A; Szczepański MA; Litwiniec A
    Postepy Hig Med Dosw (Online); 2008 Sep; 62():463-7. PubMed ID: 18806735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Arsenic trioxide: expanding roles for an ancient drug?
    Ravandi F
    Leukemia; 2004 Sep; 18(9):1457-9. PubMed ID: 15269784
    [No Abstract]   [Full Text] [Related]  

  • 31. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.
    Ning S; Knox SJ
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):197-203. PubMed ID: 15337556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Arsenic trioxide in patients with refractory multiple myeloma: a prospective, phase II, single-arm study.
    Sanaat Z; Rezazadeh M; Gharamaleki JV; Ziae JE; Esfahani A
    Acta Med Iran; 2011; 49(8):504-8. PubMed ID: 22009804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Temporary effect of arsenic trioxide treatment of refractory extragonadal germ cell cancer.
    Kälkner KM; Ullén A; Wersäll P; Cohn-Cedermark G
    Acta Oncol; 2007; 46(6):862-3. PubMed ID: 17653913
    [No Abstract]   [Full Text] [Related]  

  • 34. Role of oxidative stress in the apoptosis of hepatocellular carcinoma induced by combination of arsenic trioxide and ascorbic acid.
    Li JJ; Tang Q; Li Y; Hu BR; Ming ZY; Fu Q; Qian JQ; Xiang JZ
    Acta Pharmacol Sin; 2006 Aug; 27(8):1078-84. PubMed ID: 16867262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Arsenic trioxide induces apoptosis in cells of MOLT-4 and its daunorubicin-resistant cell line via depletion of intracellular glutathione, disruption of mitochondrial membrane potential and activation of caspase-3.
    Hu XM; Hirano T; Oka K
    Cancer Chemother Pharmacol; 2003 Jul; 52(1):47-58. PubMed ID: 12750841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase II study of arsenic trioxide and ascorbic acid for relapsed or refractory lymphoid malignancies: a Wisconsin Oncology Network study.
    Chang JE; Voorhees PM; Kolesar JM; Ahuja HG; Sanchez FA; Rodriguez GA; Kim K; Werndli J; Bailey HH; Kahl BS
    Hematol Oncol; 2009 Mar; 27(1):11-6. PubMed ID: 18668698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful pregnancy after arsenic trioxide therapy for relapsed acute promyelocytic leukaemia.
    Ammatuna E; Cavaliere A; Divona M; Amadori S; Scambia G; Lo-Coco F
    Br J Haematol; 2009 Aug; 146(3):341. PubMed ID: 19545283
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of arsenic trioxide on voltage-dependent potassium channels and on cell proliferation of human multiple myeloma cells.
    Zhou J; Wang W; Wei QF; Feng TM; Tan LJ; Yang BF
    Chin Med J (Engl); 2007 Jul; 120(14):1266-9. PubMed ID: 17697580
    [No Abstract]   [Full Text] [Related]  

  • 39. Arsenic in the cerebrospinal fluid of a patient receiving arsenic trioxide for relapsed acute promyelocytic leukemia with CNS involvement.
    Knipp S; Gattermann N; Schapira M; Käferstein H; Germing U
    Leuk Res; 2007 Nov; 31(11):1585-7. PubMed ID: 17416415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advances in management of acute promyelocytic leukemia with arsenic trioxide.
    Ma J
    Chin J Integr Med; 2007 Jun; 13(2):92-4. PubMed ID: 17609904
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.